{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:49:26Z","timestamp":1792442966192,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T00:00:00Z","timestamp":1529539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1038\/s41375-018-0176-z","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T06:33:00Z","timestamp":1529562780000},"page":"319-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL"],"prefix":"10.1038","volume":"33","author":[{"given":"Kim R.","family":"Kampen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey O.","family":"Sulima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benno","family":"Verbelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Girardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8414-8907","authenticated-orcid":false,"given":"Stijn","family":"Vereecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmarco","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"Verbeeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Op de Beeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Uyttebroeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules P. P.","family":"Meijerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony V.","family":"Moorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine J.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Spincemaille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Cools","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cassiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah-Maria","family":"Fendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Vermeersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"De Keersmaecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,21]]},"reference":[{"key":"176_CR1","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","volume":"129","author":"T Girardi","year":"2017","unstructured":"Girardi T, Vicente C, Cools J, De Keersmaecker K. The genetics and molecular biology of T-ALL. Blood. 2017;129:1113\u201323.","journal-title":"Blood"},{"key":"176_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.pcl.2014.09.006","volume":"62","author":"SL Cooper","year":"2015","unstructured":"Cooper SL, Brown PA. Treatment of pediatric acute lymphoblastic leukemia. Pediatr Clin North Am. 2015;62:61\u201373.","journal-title":"Pediatr Clin North Am"},{"key":"176_CR3","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1182\/blood-2012-03-415349","volume":"120","author":"S Rao","year":"2012","unstructured":"Rao S, Lee SY, Gutierrez A, Perrigoue J, Thapa RJ, Tu Z, et al. Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B. Blood. 2012;120:3764\u201373.","journal-title":"Blood"},{"key":"176_CR4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/ng.2508","volume":"45","author":"K Keersmaecker De","year":"2013","unstructured":"De Keersmaecker K, Atak ZK, Li N, Vicente C, Patchett S, Girardi T, et al. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nat Genet. 2013;45:186\u201390.","journal-title":"Nat Genet"},{"key":"176_CR5","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nm.3078","volume":"19","author":"G Tzoneva","year":"2013","unstructured":"Tzoneva G, Perez-Garcia A, Carpenter Z, Khiabanian H, Tosello V, Allegretta M, et al. Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL. Nat Med. 2013;19:368\u201371.","journal-title":"Nat Med"},{"key":"176_CR6","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.1073\/pnas.1400247111","volume":"111","author":"SO Sulima","year":"2014","unstructured":"Sulima SO, Patchett S, Advani VM, De Keersmaecker K, Johnson AW, Dinman JD. Bypass of the pre-60S ribosomal quality control as a pathway to oncogenesis. Proc Natl Acad Sci USA. 2014;111:5640\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"176_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1006\/bbrc.1996.5955","volume":"230","author":"H Inada","year":"1997","unstructured":"Inada H, Mukai J, Matsushima S, Tanaka T. QM is a novel zinc-binding transcription regulatory protein: its binding to c-Jun is regulated by zinc ions and phosphorylation by protein kinase C. Biochem Biophys Res Commun. 1997;230:331\u20134.","journal-title":"Biochem Biophys Res Commun"},{"key":"176_CR8","doi-asserted-by":"publisher","first-page":"6726","DOI":"10.1073\/pnas.90.14.6726","volume":"90","author":"FS Monteclaro","year":"1993","unstructured":"Monteclaro FS, Vogt PK. A Jun-binding protein related to a putative tumor suppressor. Proc Natl Acad Sci USA. 1993;90:6726\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"key":"176_CR9","doi-asserted-by":"publisher","first-page":"36489","DOI":"10.1074\/jbc.M201859200","volume":"277","author":"HS Oh","year":"2002","unstructured":"Oh HS, Kwon H, Sun SK, Yang CH. QM, a putative tumor suppressor, regulates proto-oncogene c-Yes. J Biol Chem. 2002;277:36489\u201398.","journal-title":"J Biol Chem"},{"key":"176_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/2040-2392-5-10","volume":"5","author":"AG Chiocchetti","year":"2014","unstructured":"Chiocchetti AG, Haslinger D, Boesch M, Karl T, Wiemann S, Freitag CM, et al. Protein signatures of oxidative stress response in a patient specific cell line model for autism. Mol Autism. 2014;5:10.","journal-title":"Mol Autism"},{"key":"176_CR11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/leu.2017.225","volume":"32","author":"T Girardi","year":"2017","unstructured":"Girardi T, Vereecke S, Sulima SO, Khan Y, Fancello L, Briggs JW, et al. The T-cell leukemia associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling. Leukemia. 2017;32:809\u201319.","journal-title":"Leukemia"},{"key":"176_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15267","volume":"8","author":"I Elia","year":"2017","unstructured":"Elia I, Broekaert D, Christen S, Boon R, Radaelli E, Orth MF, et al. Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells. Nat Commun. 2017;8:15267.","journal-title":"Nat Commun"},{"key":"176_CR13","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.celrep.2016.09.042","volume":"17","author":"S Christen","year":"2016","unstructured":"Christen S, Lorendeau D, Schmieder R, Broekaert D, Metzger K, Veys K, et al. Breast cancer-derived lung metastases show increased pyruvate carboxylase-dependent anaplerosis. Cell Rep. 2016;17:837\u201348.","journal-title":"Cell Rep"},{"key":"176_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ymben.2016.11.005","volume":"43","author":"D Lorendeau","year":"2016","unstructured":"Lorendeau D, Rinaldi G, Boon R, Spincemaille P, Metzger K, J\u00e4ger C, et al. Dual loss of succinate dehydrogenase (SDH) and complex I activity is necessary to recapitulate the metabolic phenotype of SDH mutant tumors. Metab Eng. 2016;43:187\u201397.","journal-title":"Metab Eng"},{"key":"176_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.molcel.2008.03.018","volume":"30","author":"L Marash","year":"2008","unstructured":"Marash L, Liberman N, Henis-Korenblit S, Sivan G, Reem E, Elroy-Stein O, et al. DAP5 promotes cap-independent translation of Bcl-2 and CDK1 to facilitate cell survival during mitosis. Mol Cell. 2008;30:447\u201359.","journal-title":"Mol Cell"},{"key":"176_CR16","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.bbadis.2011.12.001","volume":"1822","author":"M Fransen","year":"2012","unstructured":"Fransen M, Nordgren M, Wang B, Apanasets O. Role of peroxisomes in ROS\/RNS-metabolism: Implications for human disease. Biochim Biophys Acta - Mol Basis Dis. 2012;1822:1363\u201373.","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"176_CR17","doi-asserted-by":"publisher","first-page":"S293","DOI":"10.1002\/pmic.200500384","volume":"6","author":"C L\u00f3pez-Pedrera","year":"2006","unstructured":"L\u00f3pez-Pedrera C, Villalba JM, Siendones E, Barbarroja N, G\u00f3mez-D\u00edaz C, Rodr\u00edguez-Ariza A, et al. Proteomic analysis of acute myeloid leukemia: identification of potential early biomarkers and therapeutic targets. Proteomics. 2006;6:S293\u20139.","journal-title":"Proteomics"},{"key":"176_CR18","first-page":"330","volume":"15","author":"I Zelen","year":"2010","unstructured":"Zelen I, Djurdjevic P, Popovic S, Stojanovic M, Jakovljevic V, Radivojevic S, et al. Antioxidant enzymes activities and plasma levels of oxidative stress markers in B-chronic lymphocytic leukemia patients. J BUON. 2010;15:330\u20136.","journal-title":"J BUON"},{"key":"176_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.copbio.2015.02.003","volume":"34","author":"JM Buescher","year":"2015","unstructured":"Buescher JM, Antoniewicz MR, Boros LG, Burgess SC, Brunengraber H, Clish CB, et al. A roadmap for interpreting 13C metabolite labeling patterns from cells. Curr Opin Biotechnol. 2015;34:189\u2013201.","journal-title":"Curr Opin Biotechnol"},{"key":"176_CR20","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1080\/10715760903179673","volume":"43","author":"AP Kulkarni","year":"2009","unstructured":"Kulkarni AP, Mittal SPK, Devasagayam TP, Pal JK. Oxidative stress perturbs cell proliferation in human K562 cells by modulating protein synthesis and cell cycle. Free Radic Res. 2009;43:1090\u2013100.","journal-title":"Free Radic Res"},{"key":"176_CR21","first-page":"2003","volume":"8","author":"C Guo","year":"2013","unstructured":"Guo C, Sun L, Chen X, Zhang D. Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res. 2013;8:2003\u201314.","journal-title":"Neural Regen Res"},{"key":"176_CR22","doi-asserted-by":"publisher","first-page":"23357","DOI":"10.1074\/jbc.M100320200","volume":"276","author":"AC Nulton-Persson","year":"2001","unstructured":"Nulton-Persson AC, Szweda LI. Modulation of mitochondrial function by hydrogen peroxide. J Biol Chem. 2001;276:23357\u201361.","journal-title":"J Biol Chem"},{"key":"176_CR23","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.clinbiochem.2008.01.027","volume":"41","author":"V Battisti","year":"2008","unstructured":"Battisti V, Maders LDK, Bagatini MD, Santos KF, Spanevello RM, Maldonado PA, et al. Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients. Clin Biochem. 2008;41:511\u20138.","journal-title":"Clin Biochem"},{"key":"176_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2008.03.036","volume":"270","author":"A Sallmyr","year":"2008","unstructured":"Sallmyr A, Fan J, Rassool FV. Genomic instability in myeloid malignancies: Increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair. Cancer Lett. 2008;270:1\u20139.","journal-title":"Cancer Lett"},{"key":"176_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/emm.2000.8","volume":"32","author":"JE Lee","year":"2000","unstructured":"Lee JE, Sohn J, Lee JH, Lee KC, Son CS, Tockgo YC. Regulation of bcl-2 family in hydrogen peroxide-induced apoptosis in human leukemia HL-60 cells. Exp Mol Med. 2000;32:42\u20136.","journal-title":"Exp Mol Med"},{"key":"176_CR26","doi-asserted-by":"publisher","first-page":"29066","DOI":"10.1074\/jbc.M402727200","volume":"279","author":"KW Sherrill","year":"2004","unstructured":"Sherrill KW, Byrd MP, Van Eden ME, Lloyd RE. BCL-2 translation is mediated via internal ribosome entry during cell stress. J Biol Chem. 2004;279:29066\u201374.","journal-title":"J Biol Chem"},{"key":"176_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/dvdy.21046","volume":"236","author":"CB Kirn-Safran","year":"2007","unstructured":"Kirn-Safran CB, Oristian DS, Focht RJ, Parker SG, Vivian JL, Carson DD. Global growth deficiencies in mice lacking the ribosomal protein HIP\/RPL29. Dev Dyn. 2007;236:447\u201360.","journal-title":"Dev Dyn"},{"key":"176_CR28","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1128\/MCB.01174-13","volume":"33","author":"T Teng","year":"2013","unstructured":"Teng T, Mercer CA, Hexley P, Thomas G, Fumagalli S. Loss of tumor suppressor RPL5\/RPL11 does not induce cell cycle arrest but impedes proliferation due to reduced ribosome content and translation capacity. Mol Cell Biol. 2013;33:4660\u201371.","journal-title":"Mol Cell Biol"},{"key":"176_CR29","doi-asserted-by":"publisher","first-page":"29011","DOI":"10.1074\/jbc.M601545200","volume":"281","author":"D Shenton","year":"2006","unstructured":"Shenton D, Smirnova JB, Selley JN, Carroll K, Hubbard SJ, Pavitt GD, et al. Global translational responses to oxidative stress impact upon multiple levels of protein synthesis. J Biol Chem. 2006;281:29011\u201321.","journal-title":"J Biol Chem"},{"key":"176_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-015-0224-3","volume":"8","author":"S Cang","year":"2015","unstructured":"Cang S, Iragavarapu C, Savooji J, Song Y, Liu D. ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development. J Hematol Oncol. 2015;8:129.","journal-title":"J Hematol Oncol"},{"key":"176_CR31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1182\/blood.V126.23.254.254","volume":"126","author":"JF Gerecitano","year":"2015","unstructured":"Gerecitano JF, Roberts AW, Seymour JF, Wierda WG, Kahl BS, Pagel JM, et al. A phase 1 study of venetoclax (ABT-199\/GDC-0199) monotherapy in patients with relapsed\/refractory non-hodgkin lymphoma. Blood. 2015;126:254.","journal-title":"Blood"},{"key":"176_CR32","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1182\/blood-2013-05-502807","volume":"122","author":"JF Seymour","year":"2013","unstructured":"Seymour JF, Gerecitano JF, Kahl BS, Pagel JM, Wierda WG, Anderson M-A, et al. The single-agent Bcl-2 inhibitor ABT-199 (GDC-0199) in patients with relapsed\/refractory (R\/R) non-hodgkin lymphoma (NHL): responses observed in all mantle cell lymphoma (MCL) patients. Blood. 2013;122:1789.","journal-title":"Blood"},{"key":"176_CR33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1513257","volume":"374","author":"AW Roberts","year":"2016","unstructured":"Roberts AW, Davids MS, Pagel JM, Kahl BS, Puvvada SD, Gerecitano JF, et al. Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia. N Engl J Med. 2016;374:311\u201322.","journal-title":"N Engl J Med"},{"key":"176_CR34","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S1470-2045(16)30019-5","volume":"17","author":"S Stilgenbauer","year":"2016","unstructured":"Stilgenbauer S, Eichhorst B, Schetelig J, Coutre S, Seymour JF, Munir T, et al. Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study. Lancet Oncol. 2016;17:768\u201378.","journal-title":"Lancet Oncol"},{"key":"176_CR35","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1158\/2159-8290.CD-14-0353","volume":"4","author":"T Ni Chonghaile","year":"2014","unstructured":"Ni Chonghaile T, Roderick JE, Glenfield C, Ryan J, Sallan SE, Silverman LB, et al. Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199. Cancer Discov. 2014;4:1074\u201387.","journal-title":"Cancer Discov"},{"key":"176_CR36","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1182\/blood-2014-06-580480","volume":"125","author":"SL Maude","year":"2015","unstructured":"Maude SL, Dolai S, Delgado-martin C, Vincent T, Robbins A, Selvanathan A, et al. Efficacy of JAK \/ STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia. Blood. 2015;125:1759\u201368.","journal-title":"Blood"},{"key":"176_CR37","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1182\/blood-2014-05-574566","volume":"124","author":"S Peirs","year":"2014","unstructured":"Peirs S, Matthijssens F, Goossens S, Van I, de W, Ruggero K, de Bock CE, et al. ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia. Blood. 2014;124:3738\u201347.","journal-title":"Blood"},{"key":"176_CR38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1182\/blood-2016-09-738070","volume":"129","author":"V Frismantas","year":"2017","unstructured":"Frismantas V, Dobay MP, Rinaldi A, Tchinda J, Dunn SH, Kunz J, et al. Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia. Blood. 2017;129:26\u201338.","journal-title":"Blood"},{"key":"176_CR39","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1038\/leu.2017.10","volume":"31","author":"S Peirs","year":"2017","unstructured":"Peirs S, Frismantas V, Matthijssens F, Van Loocke W, Pieters T, Vandamme N, et al. Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia. Leukemia. 2017;31:2037\u201347.","journal-title":"Leukemia"},{"key":"176_CR40","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature. 2012;481:157\u201363.","journal-title":"Nature"},{"key":"176_CR41","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1182\/blood-2009-07-234963","volume":"115","author":"G Li","year":"2010","unstructured":"Li G, Miskimen KL, Wang Z, Xie XY, Brenzovich J, Ryan JJ, et al. STAT5 requires the N-domain for suppression of miR15\/16, induction of bcl-2, and survival signaling in myeloproliferative disease. Blood. 2010;115:1416\u201324.","journal-title":"Blood"},{"key":"176_CR42","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.celrep.2013.10.038","volume":"5","author":"M Waibel","year":"2013","unstructured":"Waibel M, Solomon VS, Knight DA, Ralli RA, Kim SK, Banks KM, et al. Combined targeting of JAK2 and Bcl-2\/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitors. Cell Rep. 2013;5:1047\u201359.","journal-title":"Cell Rep"},{"key":"176_CR43","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/ng.3909","volume":"49","author":"Y Liu","year":"2017","unstructured":"Liu Y, Easton J, Shao Y, Maciaszek J, Wang Z, Wilkinson MR, et al. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet. 2017;49:1211\u20138.","journal-title":"Nat Genet"},{"key":"176_CR44","doi-asserted-by":"publisher","first-page":"C1640","DOI":"10.1152\/ajpcell.1998.275.6.C1640","volume":"275","author":"AR Simon","year":"1998","unstructured":"Simon AR, Rai U, Fanburg BL, Cochran BH. Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol. 1998;275:C1640\u201352.","journal-title":"Am J Physiol"},{"key":"176_CR45","doi-asserted-by":"publisher","first-page":"R110.006924","DOI":"10.1074\/mcp.M110.006924","volume":"10","author":"CT Aiken","year":"2011","unstructured":"Aiken CT, Kaake RM, Wang X, Huang L, Stumpf MP, Mishto M, et al. Oxidative stress-mediated regulation of proteasome complexes. Mol Cell Proteom. 2011;10:R110.006924.","journal-title":"Mol Cell Proteom"},{"key":"176_CR46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","volume":"213","author":"J Maiuolo","year":"2016","unstructured":"Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol. 2016;213:8\u201314.","journal-title":"Int J Cardiol"},{"key":"176_CR47","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ccr.2013.08.013","volume":"24","author":"V Marcel","year":"2013","unstructured":"Marcel V, Ghayad SE, Belin S, Therizols G, Morel AP, Solano-Gonz\u00e0lez E, et al. P53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer. Cancer Cell. 2013;24:318\u201330.","journal-title":"Cancer Cell"},{"key":"176_CR48","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1126\/science.1123835","volume":"312","author":"A Yoon","year":"2006","unstructured":"Yoon A, Peng G, Brandenburger Y, Zollo O, Xu W, Rego ERD. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science. 2006;312:902\u20136.","journal-title":"Science"},{"key":"176_CR49","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1158\/0008-5472.CAN-09-4024","volume":"70","author":"L Montanaro","year":"2010","unstructured":"Montanaro L, Calienni M, Bertoni S, Rocchi L, Sansone P, Storci G, et al. Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation. Cancer Res. 2010;70:4767\u201377.","journal-title":"Cancer Res"},{"key":"176_CR50","doi-asserted-by":"publisher","first-page":"8308","DOI":"10.1093\/nar\/gkt587","volume":"41","author":"L Rocchi","year":"2013","unstructured":"Rocchi L, Pacilli A, Sethi R, Penzo M, Schneider RJ, Trer\u00e9 D, et al. Dyskerin depletion increases VEGF mRNA internal ribosome entry site-mediated translation. Nucleic Acids Res. 2013;41:8308\u201318.","journal-title":"Nucleic Acids Res"},{"key":"176_CR51","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1182\/blood-2011-06-358200","volume":"119","author":"R Horos","year":"2012","unstructured":"Horos R, IJspeert H, Pospisilova D, Sendtner R, Andrieu-Soler C, Taskesen E, et al. Ribosomal deficiencies in Diamond-Blackfan anemia impair translation of transcripts essential for differentiation of murine and human erythroblasts. Blood. 2012;119:262\u201372.","journal-title":"Blood"},{"key":"176_CR52","doi-asserted-by":"publisher","first-page":"D125","DOI":"10.1093\/nar\/gkj081","volume":"34","author":"M Mokrejs","year":"2006","unstructured":"Mokrejs M. IRESite: the database of experimentally verified IRES structures (www.iresite.org). Nucleic Acids Res. 2006;34:D125\u201330.","journal-title":"Nucleic Acids Res"}],"updated-by":[{"DOI":"10.1038\/s41375-019-0424-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T00:00:00Z","timestamp":1552003200000}}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0176-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0176-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0176-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:35:09Z","timestamp":1684604109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-018-0176-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,21]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["176"],"URL":"https:\/\/doi.org\/10.1038\/s41375-018-0176-z","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,21]]},"assertion":[{"value":"12 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2019","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Following the publication of this article, the authors noted that Dr Laura Fancello was not listed among the authors. The corrected author list is given in the Correction. Additionally, the following was not included in the author contribution statement: \u2018L.F. analyzed RNA sequencing data\u2019. The authors wish to apologise for any inconvenience caused.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}